Related Experiment Video

Updated: Jul 14, 2026

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis
06:46

3D Imaging of the Liver Extracellular Matrix in a Mouse Model of Non-Alcoholic Steatohepatitis

Published on: February 25, 2022

NOX in liver fibrosis

Samuele De Minicis1, David A Brenner

  • 1Department of Medicine, Columbia University, College of Physicians and Surgeons, New York, NY 10026, USA.

Archives of Biochemistry and Biophysics
|May 29, 2007
PubMed

Insights

NADPH oxidase, crucial for host defense and cell signaling, drives liver fibrosis by activating hepatic stellate cells (HSCs). Inhibiting this enzyme complex in HSCs offers a potential therapeutic target for liver fibrosis.

Area of Science:

  • Biochemistry
  • Cell Biology
  • Hepatology

Background:

  • NADPH oxidase (NOX) produces reactive oxygen species (ROS) in phagocytic and non-phagocytic cells.
  • NOX is integral to intracellular signaling and host defense mechanisms.
  • In the liver, NOX is implicated in the pathogenesis of fibrogenesis.

Purpose of the Study:

  • To investigate the role of non-phagocytic NADPH oxidase in hepatic stellate cell (HSC) activation.
  • To elucidate the mechanism by which profibrogenic stimuli activate NADPH oxidase in HSCs.
  • To assess the therapeutic potential of targeting NADPH oxidase in liver fibrosis.

Main Methods:

  • Utilized pharmacological inhibition (DPI) and genetic models (p47(phox) knockout mice).
  • Investigated NADPH oxidase activation in HSCs by profibrogenic agonists (Ang II, PDGF) and apoptotic bodies.
  • Identified key functional components of the NADPH oxidase complex in HSCs, including Rac1.

Main Results:

  • NADPH oxidase is functionally active in both Kupffer cells and HSCs.
  • Profibrogenic agonists and apoptotic bodies activate NADPH oxidase in HSCs.
  • Pharmacological and genetic inhibition of NADPH oxidase reduced HSC activity and liver fibrosis.

Conclusions:

  • Non-phagocytic NADPH oxidase plays a critical role in HSC activation and liver fibrogenesis.
  • Targeting NADPH oxidase in HSCs presents a promising strategy for treating liver fibrosis.
  • Rac1 is a key functional component of the NADPH oxidase complex in HSCs.

More Related Videos

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis08:56

Bile Duct Ligation in Mice: Induction of Inflammatory Liver Injury and Fibrosis by Obstructive Cholestasis

Published on: February 10, 2015

Related Concept Videos

Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Cirrhosis I: Introduction01:23

Cirrhosis I: Introduction

Cirrhosis is a chronic, irreversible liver disease characterized by the widespread replacement of healthy liver tissue with fibrotic scar tissue and the formation of regenerative nodules.Etiology of cirrhosisCirrhosis results from sustained liver injury that triggers progressive fibrosis and structural remodeling. The underlying causes are diverse, encompassing common and less frequent clinical conditions. Regardless of the origin, all causes lead to chronic inflammation, hepatocyte loss, and...
Liver Regeneration01:24

Liver Regeneration

The liver is an important organ in vertebrates that plays an essential role in metabolism. It is also responsible for storing and redistributing nutrients such as carbohydrates, fats, and vitamins in the body. Additionally, the liver releases bile salts which are critical for digesting food and eliminating toxic metabolites from the body.
Cells of Liver
The liver comprises four major types of cells— hepatocytes, stellate, Kupffer, and sinusoidal endothelial cells. The hepatocytes are large...
Ultrasound II: Endoscopic Ultrasound and FibroScan01:25

Ultrasound II: Endoscopic Ultrasound and FibroScan

Endoscopic Ultrasound (EUS) and FibroScan are valuable diagnostic tools in gastroenterology and hepatology, each with specific applications and techniques.
Endoscopic Ultrasound (EUS):
Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow01:26

Effect of Hepatic Disease on Pharmacokinetics: Drug Dosing and Hepatic Blood Flow

Chronic liver disease significantly impacts drug metabolism due to alterations in hepatic blood flow and enzyme accessibility. This disruption affects the body's pharmacokinetics—the movement and processing of drugs within the system. Key enzymes crucial for metabolizing medications become less accessible, changing how drugs are processed and utilized. Furthermore, liver disease influences the synthesis of plasma proteins, such as albumin and globulins, which play critical roles in drug binding...